Home › U.S. Food and Drug Administration Approves POMALYST (pomalidomide)...
 

Keywords :   


U.S. Food and Drug Administration Approves POMALYST (pomalidomide)...

2013-02-09 07:14:10| Biotech - Topix.net

Celgene Corporation today announced the U.S. Food and Drug Administration has approved POMALYSTA brand therapy for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Tags: food administration drug drug administration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Hurricane Leslie Graphics
06.10Hurricane Kirk Graphics
06.10Hurricane Leslie Forecast Discussion Number 15
06.10Hurricane Leslie Wind Speed Probabilities Number 15
06.10Hurricane Leslie Public Advisory Number 15
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Leslie Forecast Advisory Number 15
06.10Hurricane Kirk Forecast Discussion Number 27
More »